Mutations profile of polycythemia vera and essential thrombocythemia among Japanese children

Olfat Ismael, Akira Shimada, Asahito Hama, Hiroshi Sakaguchi, Sayoko Doisaki, Hideki Muramatsu, Nao Yoshida, Masafumi Ito, Yoshiyuki Takahashi, Naohiro Akita, Shosuke Sunami, Yoshitoshi Ohtsuka, Youji Asada, Hiroyuki Fujisaki, Seiji Kojima

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background: Acquired somatic mutations of JAK2 have been reported to play a pivotal role in the pathogenesis of BCR-ABL1-negative myeloproliferative neoplasm (MPN). However, the molecular characteristics of childhood MPN remain to be elucidated. Patient and Methods: We investigated a group of pediatric patients diagnosed either with essential thrombocythemia (ET; N=9) or polycythemia vera (PV; N=4) according to WHO criteria (median age=10 years; range 1.5-15 years) in whom direct sequencing was performed for the existence of genetic alterations in JAK2, MPL, TET2, ASXL1, CBL, IDH1, and IDH2. More sensitive allele specific polymerase chain reaction was used for JAK2 V617F genotyping. Results: We found three patients harbor JAK2 V617F mutation (2/9 ET and 1/4 PV). Bone marrow examination showed small and large megakaryocytes with dysplastic features in JAK2 V617F-positive ET patients compared to those without JAK2 V617F. We identified a previously unrecognized missense mutation at codon 1230 in exon 12 of ASXL1 gene in ET and PV patients (1/9 ET and 1/4 PV). Otherwise, no genetic alterations could be detected in JAK2 exon 12, MPL, TET2, CBL, IDH1, and IDH2 in all ET and PV patients. Conclusion: Although JAK2 mutations in childhood ET and PV are not as frequent as reported in adult patients, JAK2 is the most frequently mutated gene in childhood MPN known so far. Owing to the presence of childhood MPN without any genetic alterations in JAK2, MPL, TET2, ASXL1, CBL, IDH1, and IDH2, new biological markers have to be found.

Original languageEnglish
Pages (from-to)530-535
Number of pages6
JournalPediatric Blood and Cancer
Volume59
Issue number3
DOIs
Publication statusPublished - Sep 2012
Externally publishedYes

Fingerprint

Essential Thrombocythemia
Polycythemia Vera
Mutation
Exons
Neoplasms
Bone Marrow Examination
Megakaryocytes
Missense Mutation
Codon
Genes
Biomarkers
Alleles
Pediatrics
Polymerase Chain Reaction

Keywords

  • ASXL1
  • Essential thrombocythemia
  • JAK2
  • Mutation
  • Polycythemia vera

ASJC Scopus subject areas

  • Oncology
  • Pediatrics, Perinatology, and Child Health
  • Hematology

Cite this

Mutations profile of polycythemia vera and essential thrombocythemia among Japanese children. / Ismael, Olfat; Shimada, Akira; Hama, Asahito; Sakaguchi, Hiroshi; Doisaki, Sayoko; Muramatsu, Hideki; Yoshida, Nao; Ito, Masafumi; Takahashi, Yoshiyuki; Akita, Naohiro; Sunami, Shosuke; Ohtsuka, Yoshitoshi; Asada, Youji; Fujisaki, Hiroyuki; Kojima, Seiji.

In: Pediatric Blood and Cancer, Vol. 59, No. 3, 09.2012, p. 530-535.

Research output: Contribution to journalArticle

Ismael, O, Shimada, A, Hama, A, Sakaguchi, H, Doisaki, S, Muramatsu, H, Yoshida, N, Ito, M, Takahashi, Y, Akita, N, Sunami, S, Ohtsuka, Y, Asada, Y, Fujisaki, H & Kojima, S 2012, 'Mutations profile of polycythemia vera and essential thrombocythemia among Japanese children', Pediatric Blood and Cancer, vol. 59, no. 3, pp. 530-535. https://doi.org/10.1002/pbc.23409
Ismael, Olfat ; Shimada, Akira ; Hama, Asahito ; Sakaguchi, Hiroshi ; Doisaki, Sayoko ; Muramatsu, Hideki ; Yoshida, Nao ; Ito, Masafumi ; Takahashi, Yoshiyuki ; Akita, Naohiro ; Sunami, Shosuke ; Ohtsuka, Yoshitoshi ; Asada, Youji ; Fujisaki, Hiroyuki ; Kojima, Seiji. / Mutations profile of polycythemia vera and essential thrombocythemia among Japanese children. In: Pediatric Blood and Cancer. 2012 ; Vol. 59, No. 3. pp. 530-535.
@article{03374473918f4b478a5c04c02380e315,
title = "Mutations profile of polycythemia vera and essential thrombocythemia among Japanese children",
abstract = "Background: Acquired somatic mutations of JAK2 have been reported to play a pivotal role in the pathogenesis of BCR-ABL1-negative myeloproliferative neoplasm (MPN). However, the molecular characteristics of childhood MPN remain to be elucidated. Patient and Methods: We investigated a group of pediatric patients diagnosed either with essential thrombocythemia (ET; N=9) or polycythemia vera (PV; N=4) according to WHO criteria (median age=10 years; range 1.5-15 years) in whom direct sequencing was performed for the existence of genetic alterations in JAK2, MPL, TET2, ASXL1, CBL, IDH1, and IDH2. More sensitive allele specific polymerase chain reaction was used for JAK2 V617F genotyping. Results: We found three patients harbor JAK2 V617F mutation (2/9 ET and 1/4 PV). Bone marrow examination showed small and large megakaryocytes with dysplastic features in JAK2 V617F-positive ET patients compared to those without JAK2 V617F. We identified a previously unrecognized missense mutation at codon 1230 in exon 12 of ASXL1 gene in ET and PV patients (1/9 ET and 1/4 PV). Otherwise, no genetic alterations could be detected in JAK2 exon 12, MPL, TET2, CBL, IDH1, and IDH2 in all ET and PV patients. Conclusion: Although JAK2 mutations in childhood ET and PV are not as frequent as reported in adult patients, JAK2 is the most frequently mutated gene in childhood MPN known so far. Owing to the presence of childhood MPN without any genetic alterations in JAK2, MPL, TET2, ASXL1, CBL, IDH1, and IDH2, new biological markers have to be found.",
keywords = "ASXL1, Essential thrombocythemia, JAK2, Mutation, Polycythemia vera",
author = "Olfat Ismael and Akira Shimada and Asahito Hama and Hiroshi Sakaguchi and Sayoko Doisaki and Hideki Muramatsu and Nao Yoshida and Masafumi Ito and Yoshiyuki Takahashi and Naohiro Akita and Shosuke Sunami and Yoshitoshi Ohtsuka and Youji Asada and Hiroyuki Fujisaki and Seiji Kojima",
year = "2012",
month = "9",
doi = "10.1002/pbc.23409",
language = "English",
volume = "59",
pages = "530--535",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Mutations profile of polycythemia vera and essential thrombocythemia among Japanese children

AU - Ismael, Olfat

AU - Shimada, Akira

AU - Hama, Asahito

AU - Sakaguchi, Hiroshi

AU - Doisaki, Sayoko

AU - Muramatsu, Hideki

AU - Yoshida, Nao

AU - Ito, Masafumi

AU - Takahashi, Yoshiyuki

AU - Akita, Naohiro

AU - Sunami, Shosuke

AU - Ohtsuka, Yoshitoshi

AU - Asada, Youji

AU - Fujisaki, Hiroyuki

AU - Kojima, Seiji

PY - 2012/9

Y1 - 2012/9

N2 - Background: Acquired somatic mutations of JAK2 have been reported to play a pivotal role in the pathogenesis of BCR-ABL1-negative myeloproliferative neoplasm (MPN). However, the molecular characteristics of childhood MPN remain to be elucidated. Patient and Methods: We investigated a group of pediatric patients diagnosed either with essential thrombocythemia (ET; N=9) or polycythemia vera (PV; N=4) according to WHO criteria (median age=10 years; range 1.5-15 years) in whom direct sequencing was performed for the existence of genetic alterations in JAK2, MPL, TET2, ASXL1, CBL, IDH1, and IDH2. More sensitive allele specific polymerase chain reaction was used for JAK2 V617F genotyping. Results: We found three patients harbor JAK2 V617F mutation (2/9 ET and 1/4 PV). Bone marrow examination showed small and large megakaryocytes with dysplastic features in JAK2 V617F-positive ET patients compared to those without JAK2 V617F. We identified a previously unrecognized missense mutation at codon 1230 in exon 12 of ASXL1 gene in ET and PV patients (1/9 ET and 1/4 PV). Otherwise, no genetic alterations could be detected in JAK2 exon 12, MPL, TET2, CBL, IDH1, and IDH2 in all ET and PV patients. Conclusion: Although JAK2 mutations in childhood ET and PV are not as frequent as reported in adult patients, JAK2 is the most frequently mutated gene in childhood MPN known so far. Owing to the presence of childhood MPN without any genetic alterations in JAK2, MPL, TET2, ASXL1, CBL, IDH1, and IDH2, new biological markers have to be found.

AB - Background: Acquired somatic mutations of JAK2 have been reported to play a pivotal role in the pathogenesis of BCR-ABL1-negative myeloproliferative neoplasm (MPN). However, the molecular characteristics of childhood MPN remain to be elucidated. Patient and Methods: We investigated a group of pediatric patients diagnosed either with essential thrombocythemia (ET; N=9) or polycythemia vera (PV; N=4) according to WHO criteria (median age=10 years; range 1.5-15 years) in whom direct sequencing was performed for the existence of genetic alterations in JAK2, MPL, TET2, ASXL1, CBL, IDH1, and IDH2. More sensitive allele specific polymerase chain reaction was used for JAK2 V617F genotyping. Results: We found three patients harbor JAK2 V617F mutation (2/9 ET and 1/4 PV). Bone marrow examination showed small and large megakaryocytes with dysplastic features in JAK2 V617F-positive ET patients compared to those without JAK2 V617F. We identified a previously unrecognized missense mutation at codon 1230 in exon 12 of ASXL1 gene in ET and PV patients (1/9 ET and 1/4 PV). Otherwise, no genetic alterations could be detected in JAK2 exon 12, MPL, TET2, CBL, IDH1, and IDH2 in all ET and PV patients. Conclusion: Although JAK2 mutations in childhood ET and PV are not as frequent as reported in adult patients, JAK2 is the most frequently mutated gene in childhood MPN known so far. Owing to the presence of childhood MPN without any genetic alterations in JAK2, MPL, TET2, ASXL1, CBL, IDH1, and IDH2, new biological markers have to be found.

KW - ASXL1

KW - Essential thrombocythemia

KW - JAK2

KW - Mutation

KW - Polycythemia vera

UR - http://www.scopus.com/inward/record.url?scp=84863880827&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863880827&partnerID=8YFLogxK

U2 - 10.1002/pbc.23409

DO - 10.1002/pbc.23409

M3 - Article

C2 - 22106054

AN - SCOPUS:84863880827

VL - 59

SP - 530

EP - 535

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 3

ER -